Cohort of Peripheral T Cell Lymphoma

ClinicalTrials.gov ID

NCT02364466

Lead Sponsor

Korea Cancer Center HospitalOTHER

Overall Status

Unknown status

Study Type

Observational

Enrollment

200Estimated

Last Update Posted

Feb 18, 2015Estimated

Start Date

Jan 2015

Primary Completion Date

Dec 2019Estimated

Completion Date

Dec 2019Estimated

Official Title

Multicenter Prospective Cohort Study of Peripheral T Cell Lymphoma

Brief Summary

Prospective, observational cohort study of peripheral T cell lymphoma. Purpose is to investigate the complication including febrile neutropenia in the era of pegylated G-CSF prophylaxis.

Detailed Description

Prospective evaluation of frequencies of febrile neutropenia or infectious complications in a homogeneous population of patients with peripheral T cell lymphoma

• Lymphoma, T-Cell, Peripheral
• Febrile Neutropenia

Ages Eligible for Study

Adult (18-64)Older Adult (65+)

Sexes Eligible for Study

All

Accepts Healthy Volunteers

No

Eligibility Criteria

Inclusion Criteria:

1. Treatment naive peripheral T cell lymphoma

   Subtypes are as followings:

   Anaplastic large cell lymphoma angioimmunoblastic T cell lymphoma Peripheral T cell lymphoma-NOS Enteropathy-associated T cell lymphoma Hepatosplenic T-cell lymphoma Subcutaneous panniculitis-like T-cell lymphoma Primary cutaneous gamma-delta T-cell lymphoma Primary cutaneous CD8+ aggressive epidermotropic lymphoma

2. Scheduled to receive chemotherapy of curative intent

3. 19 years old or over

4. Expected survival is more than 6 months

5. Informed consent

Exclusion Criteria:

1. Other histology than those described above

   • Extranodal NK/T cell lymphoma
   • Other than peripheral T cell lymphoma

2. Other combined malignancy

3. Previous history of chemotherapy or radiation therapy

4. No informed consent

Observational Model

Cohort

Time Perspective

Prospective

Lead Sponsor

Korea Cancer Center HospitalOTHER

Collaborators

Samsung Medical CenterOTHER

Asan Medical CenterOTHER

Keimyung University Dongsan Medical CenterOTHER

Kosin University Gospel HospitalOTHER

Dankook UniversityOTHER

Soonchunhyang University HospitalOTHER

Ajou University School of MedicineOTHER

Yeungnam University HospitalOTHER

Ulsan University HospitalOTHER

Inje UniversityOTHER

Chung-Ang University HospitalOTHER

Hallym University Medical CenterOTHER

Hanyang University Seoul HospitalOTHER

Seoul National University HospitalOTHER

Pusan National University HospitalOTHER

National Health Insurance Service Ilsan HospitalOTHER

Hanyang UniversityOTHER

baramg@hanmail.net+82-2970-1246

• Multicenter Prospective Registry Study of Diffuse Large B Cell Lymphoma

  NCT02474550

  Unknown statusObservationalUpdated Jan 26, 2017
• A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy

  NCT00883181

  CompletedObservationalUpdated Mar 15, 2017
• Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

  NCT03964480

  RecruitingObservationalUpdated May 6, 2025
• Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

  NCT02178475

  CompletedObservationalUpdated Jul 23, 2018
• Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

  NCT01110733

  CompletedObservationalUpdated Jan 13, 2020
• Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia

  NCT02282215

  CompletedInterventionalPhase 2Updated Sep 27, 2018